Your browser doesn't support javascript.
SARS-CoV-2 vaccination for patients with inflammatory bowel disease.
Garrido, Hannah M Garcia; Grobusch, Martin P; D'Haens, Geert R A M; Goorhuis, Abraham.
  • Garrido HMG; Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands.
  • Grobusch MP; Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands.
  • D'Haens GRAM; Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands.
  • Goorhuis A; Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands. Electronic address: a.goorhuis@amsterdamumc.nl.
Lancet Gastroenterol Hepatol ; 6(7): 523, 2021 07.
Article in English | MEDLINE | ID: covidwho-1263400

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Gastroenterology / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2021 Document Type: Article Affiliation country: S2468-1253(21)00148-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Gastroenterology / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2021 Document Type: Article Affiliation country: S2468-1253(21)00148-5